The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II trial of mFOLFOX6 plus bevacizumab as treatment for liver-only metastases from colorectal cancer unsuitable for upfront resection (TRICC0808): Final analysis for survival.
 
Hiroshi Tamagawa
Consulting or Advisory Role - Takeda
 
Hiroyuki Uetake
Honoraria - Chugai Pharma; Yakult Honsha
Research Funding - Chugai Pharma; Yakult Honsha
 
Megumi Ishiguro
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical; Yakult Honsha
 
Nobuyuki Mizunuma
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Yusuke Kinugasa
No Relationships to Disclose
 
Izumi Mochizuki
No Relationships to Disclose
 
Tetsuya Hamaguchi
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - NanoCarrier
Research Funding - NanoCarrier; Sanofi; Sumitomo Dainippon
 
Junichi Hasegawa
No Relationships to Disclose
 
Kenji Katsumata
No Relationships to Disclose
 
Keiichiro Ishibashi
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Yutaka Ogata
No Relationships to Disclose
 
Yasumasa Takii
No Relationships to Disclose
 
Mitsuru Ooshiro
No Relationships to Disclose
 
Tatsuo Kagimura
No Relationships to Disclose
 
Kenichi Sugihara
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Merck Serono; Taiho Pharmaceutical
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha